BlackRock Health Sciences Trust II — Form 8-K Summary
Reporting date: March 16, 2020; earliest event reported March 16, 2020. The filing was submitted under Item 8.01, “Other Events.” The registrant identified in the filing is BlackRock Health Sciences Trust II, trading under the symbol BMEZ on the New York Stock Exchange.
Business Context and Reporting Period
The filing provides an update to risk disclosures concerning the coronavirus outbreak, first detected in China in December 2019 and subsequently spreading internationally. It does not report quarterly or annual operating results.
Financial Metrics and Liquidity
- Revenue, net investment income, earnings, margins, assets, cash flow, debt, liquidity, and net asset value: the filing text does not provide clear values.
- No dividend, distribution, share issuance, repurchase, or portfolio transaction information is disclosed.
Material Changes and Risk Update
The registrant added or updated disclosure regarding the potential effects of the coronavirus outbreak and future epidemics or pandemics. Identified effects include border closures, enhanced health screenings, healthcare preparation and delivery, quarantines, cancellations, supply-chain disruptions, reduced customer activity, economic uncertainty, and market-wide volatility.
The filing states that impacts may affect economies, individual companies, and financial markets in ways that cannot presently be foreseen. It also notes that infectious-disease effects may be greater in developing or emerging-market countries because of less-established healthcare systems, and may aggravate existing political, social, and economic risks.
Guidance, Outlook, and Contingencies
No quantitative guidance or earnings outlook is provided. Management does not specify the expected duration or financial magnitude of the coronavirus-related effects, stating that the impact could be short term or extended.
Key Facts for Investors to Verify
- Confirm the registrant’s legal name: the filing states “BlackRock Health Sciences Trust II,” while the request metadata refers to “Blackrock Health Sciences Term Trust.”
- Assess subsequent filings for realized effects on portfolio values, net asset value, market price, distributions, leverage, and liquidity.
- Review later disclosures for the duration and severity of coronavirus-related market and operational impacts.
- Note that this 8-K is a risk update only and does not contain current financial results or quantitative estimates.